• 29113 Citations
  • 85 h-Index
1981 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Review article

α1-Adrenoceptor subtypes and lower urinary tract symptoms

Schwinn, D. A. & Roehrborn, C., Mar 2008, In : International Journal of Urology. 15, 3, p. 193-199 7 p.

Research output: Contribution to journalReview article

131 Scopus citations

α1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia

Roehrborn, C. & Schwinn, D. A., Mar 2004, In : Journal of Urology. 171, 3, p. 1029-1035 7 p.

Research output: Contribution to journalReview article

217 Scopus citations

Urinary Retention and Post-Void Residual Urine in Men: Separating Truth From Tradition

Kaplan, S. A., Wein, A. J., Staskin, D. R., Roehrborn, C. & Steers, W. D., Jul 1 2008, In : Journal of Urology. 180, 1, p. 47-54 8 p.

Research output: Contribution to journalReview article

96 Scopus citations

Update on prostate-specific antigen testing for the early detection of prostate cancer

Terrell, J. D., Roehrborn, C., Wians, F. H., Karakiewicz, P. I. & Shariat, S. F., Dec 1 2008, In : Laboratory Medicine. 39, 10, p. 613-621 9 p.

Research output: Contribution to journalReview article

2 Scopus citations
24 Scopus citations

The role of the general practitioner in the diagnosis and treatment of benign prostatic hyperplasia (BPH).

Janknegt, R. A. & Roehrborn, C. G., 1994, In : Progress in clinical and biological research. 386, p. 313-329 17 p.

Research output: Contribution to journalReview article

2 Scopus citations

The role of novel minimally invasive treatments for lower urinary tract symptoms associated with benign prostatic hyperplasia

Madersbacher, S., Roehrborn, C. G. & Oelke, M., Sep 1 2020, In : BJU international. 126, 3, p. 317-326 10 p.

Research output: Contribution to journalReview article

1 Scopus citations

The Interpretation of Serum Prostate Specific Antigen in Men Receiving 5α-Reductase Inhibitors: A Review and Clinical Recommendations

Marks, L. S., Andriole, G. L., Fitzpatrick, J. M., Schulman, C. C. & Roehrborn, C., Sep 1 2006, In : Journal of Urology. 176, 3, p. 868-874 7 p.

Research output: Contribution to journalReview article

58 Scopus citations

The effects of 5α-reductase inhibitors on the natural history, detection and grading of prostate cancer: Current state of knowledge

Andriole, G., Bostwick, D., Civantos, F., Epstein, J., Lucia, M. S., McConnell, J. & Roehrborn, C., Dec 2005, In : Journal of Urology. 174, 6, p. 2098-2104 7 p.

Research output: Contribution to journalReview article

48 Scopus citations

The assessment of patient complaints.

Roehrborn, C., 1994, In : Progress in clinical and biological research. 386, p. 73-96 24 p.

Research output: Contribution to journalReview article

5 Scopus citations

The assessment of medical treatment for benign prostatic hyperplasia (BPH).

Roehrborn, C., 1994, In : Progress in clinical and biological research. 386, p. 175-190 16 p.

Research output: Contribution to journalReview article

3 Scopus citations

The appropriate evaluation of the benign prostatic hyperplasia patient

Roehrborn, C., Jan 1 1994, In : Current opinion in urology. 4, 1, p. 7-15 9 p.

Research output: Contribution to journalReview article

25 Scopus citations

Targeting phenotypic heterogeneity in benign prostatic hyperplasia

Strand, D. W., Costa, D. N., Francis, F., Ricke, W. A. & Roehrborn, C., Jul 1 2017, In : Differentiation. 96, p. 49-61 13 p.

Research output: Contribution to journalReview article

17 Scopus citations

Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: Pathophysiology and mechanism(s) of action

Andersson, K. E., De Groat, W. C., McVary, K. T., Lue, T. F., Maggi, M., Roehrborn, C., Wyndaele, J. J., Melby, T. & Viktrup, L., Mar 2011, In : Neurourology and urodynamics. 30, 3, p. 292-301 10 p.

Research output: Contribution to journalReview article

174 Scopus citations

Systematic review of combination drug therapy for non-neurogenic male lower urinary tract symptoms

Füllhase, C., Chapple, C., Cornu, J. N., De Nunzio, C., Gratzke, C., Kaplan, S. A., Marberger, M., Montorsi, F., Novara, G., Oelke, M., Porst, H., Roehrborn, C., Stief, C. & McVary, K. T., Aug 2013, In : European urology. 64, 2, p. 228-243 16 p.

Research output: Contribution to journalReview article

73 Scopus citations

Special applications of flexible deflectable ureterorenoscopy.

Preminger, G. M. & Roehrborn, C., Feb 1989, In : Seminars in urology. 7, 1, p. 16-24 9 p.

Research output: Contribution to journalReview article

6 Scopus citations
17 Scopus citations

Predictors of costs for robotic-assisted laparoscopic radical prostatectomy

Bolenz, C., Gupta, A., Roehrborn, C. & Lotan, Y., May 1 2011, In : Urologic Oncology: Seminars and Original Investigations. 29, 3, p. 325-329 5 p.

Research output: Contribution to journalReview article

11 Scopus citations

Pathology of benign prostatic hyperplasia

Roehrborn, C., Dec 1 2008, In : International Journal of Impotence Research. 20, SUPPL. 3, p. S11-S18

Research output: Contribution to journalReview article

160 Scopus citations

Over-the-counter medication availability could augment self-management of male lower urinary tract symptoms

Roehrborn, C., Miner, M. M. & Sadovsky, R., Jul 4 2018, In : Postgraduate medicine. 130, 5, p. 452-460 9 p.

Research output: Contribution to journalReview article

1 Scopus citations

Office-based therapies for benign prostatic hyperplasia: a review and update

Das, A. K., Leong, J. Y. & Roehrborn, C. G., Aug 1 2019, In : The Canadian journal of urology. 26, 4, p. 2-7 6 p.

Research output: Contribution to journalReview article

5 Scopus citations

Medical therapy options for aging men with benign prostatic hyperplasia: Focus on alfuzosin 10 mg once daily

Roehrborn, C. & Rosen, R. C., Nov 4 2008, In : Clinical interventions in aging. 3, 3, p. 511-524 14 p.

Research output: Contribution to journalReview article

41 Scopus citations

Medical Management for BPH: The Role of Combination Therapy

Roehrborn, C. & Heaton, J. P. W., Aug 1 2006, In : European Urology, Supplements. 5, 12, p. 716-721 6 p.

Research output: Contribution to journalReview article

5 Scopus citations

Management of benign prostatic hyperplasia

Barry, M. & Roehrborn, C., Mar 13 1997, In : Annual review of medicine. 48, p. 177-189 13 p.

Research output: Contribution to journalReview article

31 Scopus citations

Male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH)

Roehrborn, C., Jan 1 2011, In : Medical Clinics of North America. 95, 1, p. 87-100 14 p.

Research output: Contribution to journalReview article

137 Scopus citations

Lower Urinary Tract Symptoms Revisited: A Broader Clinical Perspective

Chapple, C. R., Wein, A. J., Abrams, P., Dmochowski, R. R., Giuliano, F., Kaplan, S. A., McVary, K. T. & Roehrborn, C., Sep 2008, In : European urology. 54, 3, p. 563-569 7 p.

Research output: Contribution to journalReview article

135 Scopus citations

Latest Evidence on the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

Gacci, M., Andersson, K. E., Chapple, C., Maggi, M., Mirone, V., Oelke, M., Porst, H., Roehrborn, C., Stief, C. & Giuliano, F., Jul 1 2016, In : European urology. 70, 1, p. 124-133 10 p.

Research output: Contribution to journalReview article

65 Scopus citations

Is there a place for combination medical therapy?

Roehrborn, C., Jan 17 2001, In : Current opinion in urology. 11, 1, p. 17-25 9 p.

Research output: Contribution to journalReview article

5 Scopus citations

Is screening for prostate cancer necessary in men with symptoms of benign prostatic hyperplasia?

Hall, M. C., Roehrborn, C. & McConnell, J. D., Aug 27 1996, In : Seminars in Urologic Oncology. 14, 3, p. 122-133 12 p.

Research output: Contribution to journalReview article

9 Scopus citations

Incorporation and adaptation of intestinal segments into the urinary tract

Djavan, B. & Roehrborn, C., Jan 1 1998, In : Acta Chirurgica Austriaca. 30, 4, p. 227-234 8 p.

Research output: Contribution to journalReview article

Incidence and risk reduction of long-term outcomes: A comparison of benign prostatic hyperplasia with several other disease areas

Roehrborn, C., Dolte, K. S., Ross, K. S. & Girman, C. J., Jul 1 2000, In : Urology. 56, 1, p. 9-18 10 p.

Research output: Contribution to journalReview article

5 Scopus citations

Implications of recent epidemiology studies for the clinical management of lower urinary tract symptoms

Kaplan, S. A., Roehrborn, C., Chapple, C. R., Rosen, R. C., Irwin, D. E., Kopp, Z., Aiyer, L. P. & Mollon, P., Apr 2009, In : BJU international. 103, SUPPL. 3, p. 48-57 10 p.

Research output: Contribution to journalReview article

26 Scopus citations

Guidelines for the diagnosis and treatment of benign prostatic hyperplasia: A comparative, international overview

Roehrborn, C., Bartsch, G., Kirby, R., Andriole, G., Boyle, P., De La Rosette, J., Perrin, P., Ramsey, E., Nordling, J., De Campos Freire, G. & Arap, S., Nov 27 2001, In : Urology. 58, 5, p. 642-650 9 p.

Research output: Contribution to journalReview article

108 Scopus citations

Extracts from "clinical evidence": Benign prostatic hyperplasia

Barry, M. J. & Roehrborn, C., Nov 3 2001, In : British Medical Journal. 323, 7320, p. 1042-1046 5 p.

Research output: Contribution to journalReview article

48 Scopus citations

Endocrine therapies for BPH: scientific rationale, clinical results, and patient selection.

Oesterling, J. E., el Etreby, M. F., Gormley, G. J., Imperato-McGinley, J. L., Roehrborn, C., Schröder, F. H. & Tunn, U. W., 1994, In : Progress in clinical and biological research. 386, p. 231-250 20 p.

Research output: Contribution to journalReview article

3 Scopus citations

Emerging Minimally Invasive Treatment Options for Male Lower Urinary Tract Symptoms[Figure presented]

Magistro, G., Chapple, C. R., Elhilali, M., Gilling, P., McVary, K. T., Roehrborn, C., Stief, C. G., Woo, H. H. & Gratzke, C., Dec 2017, In : European urology. 72, 6, p. 986-997 12 p.

Research output: Contribution to journalReview article

35 Scopus citations

Does Finasteride Alter the Pathology of the Prostate and Cancer Grading?

Bostwick, D. G., Qian, J., Civantos, F., Roehrborn, C. & Montironi, R., Mar 2004, In : Clinical Prostate Cancer. 2, 4, p. 228-235 8 p.

Research output: Contribution to journalReview article

62 Scopus citations

Definition of at-risk patients: Baseline variables

Roehrborn, C., Apr 1 2006, In : BJU international. 97, SUPPL. 2, p. 7-11 5 p.

Research output: Contribution to journalReview article

84 Scopus citations

Currently available treatment guidelines for men with lower urinary tract symptoms

Roehrborn, C., Nov 2008, In : BJU international. 102, SUPPL. 2, p. 18-23 6 p.

Research output: Contribution to journalReview article

9 Scopus citations

Critical review of lasers in benign prostatic hyperplasia (BPH)

Gravas, S., Bachmann, A., Reich, O., Roehrborn, C., Gilling, P. J. & De La Rosette, J., Apr 1 2011, In : BJU international. 107, 7, p. 1030-1043 14 p.

Research output: Contribution to journalReview article

109 Scopus citations

Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia

Gacci, M., Eardley, I., Giuliano, F., Hatzichristou, D., Kaplan, S. A., Maggi, M., McVary, K. T., Mirone, V., Porst, H. & Roehrborn, C., Oct 1 2011, In : European urology. 60, 4, p. 809-825 17 p.

Research output: Contribution to journalReview article

187 Scopus citations

Clinical management of lower urinary tract symptoms with combined medical therapy

Roehrborn, C., Nov 1 2008, In : BJU international. 102, SUPPL. 2, p. 13-17 5 p.

Research output: Contribution to journalReview article

10 Scopus citations

BPH progression: Concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE

Roehrborn, C., Mar 1 2008, In : BJU International, Supplement. 101, SUPPL. 3, p. 17-21 5 p.

Research output: Contribution to journalReview article

132 Scopus citations

Blood biomarkers for prostate cancer detection and prognosis

Shariat, S. F., Karam, J. A. & Roehrborn, C., Aug 1 2007, In : Future Oncology. 3, 4, p. 449-461 13 p.

Research output: Contribution to journalReview article

19 Scopus citations

Bladder ultrasonography

Djavan, B. & Roehrborn, C., Jan 1 1994, In : Seminars in urology. 12, 4, p. 306-319 14 p.

Research output: Contribution to journalReview article

3 Scopus citations

Benign prostatic hyperplasia.

Barry, M. & Roehrborn, C., Jun 2002, In : Clinical evidence. 7, p. 775-787 13 p.

Research output: Contribution to journalReview article

3 Scopus citations

Benign prostatic hyperplasia.

Barry, M., Roehrborn, C. & Webber, R., Dec 2002, In : Clinical evidence. 8, p. 849-863 15 p.

Research output: Contribution to journalReview article

2 Scopus citations

Benign prostatic hyperplasia: A progressive disease of aging men

Emberton, M., Andriole, G. L., De La Rosette, J., Djavan, B., Hoefner, K., Vela Navarrete, R., Nordling, J., Roehrborn, C., Schulman, C., Teillac, P., Tubaro, A. & Nickel, J. C., Feb 1 2003, In : Urology. 61, 2, p. 267-273 7 p.

Research output: Contribution to journalReview article

162 Scopus citations